OSEBX1,423.56+0.84%
EQNR284.60+4.20%
DNB198.35-1.15%
MOWI172.80+0.45%
Brent$71.24-0.32%
EUR/USD1.0824-0.14%
DXY104.18+0.08%
INDICATIVE · SAMPLE DATA
SNBR$1.6058

Sleep Number Corp

Home FurnishingsVerified

Sleep Number's capital structure is highly leveraged, with total liabilities of $1.26 billion and total equity of -$578.5 million, resulting in a debt-to-equity ratio of -1.02. The company's liquidity position is weak, with cash and equivalents of only $1.69 million and a current ratio of 0.16, indicating significant short-term liquidity risk. Profitability metrics show a deteriorating trend, with a net loss of $131.96 million and an operating loss of $46.59 million in the latest period. Return on equity is 22.81%, but this is misleading due to the negative equity base. Return on assets is -19.4%, well below the typical performance of the Home Furnishings industry. The company's revenue is concentrated in the U.S. market, with no material international exposure disclosed. Sleep Number's product portfolio is centered on adjustable beds and related accessories, with no material diversification into other home furnishings categories. Growth prospects are mixed. While the company maintains a market cap of $36.87 million, it has not demonstrated consistent revenue growth in recent periods. The operating cash flow is negative at -$3.28 million, and free cash flow is -$90.76 million, indicating a lack of cash generation to support expansion. The risk profile is elevated, with a medium liquidity risk and a negative net cash position after subtracting total debt. The company has not issued any dilutive shares in the latest period, and the dilution risk is currently low. However, the negative equity position and high leverage could necessitate future capital raises, which would increase dilution risk. Recent filings and transcripts show that Sleep Number is focusing on cost optimization and inventory management to improve its financial position. Analysts have assigned a mean price target of $4.50, with all four recommendations being "Hold".

30-day price · SNBR+0.81 (+39.7%)
Low$1.06High$4.24Close$2.85As of10 May, 00:00 UTC
Profile
CompanySleep Number Corp
TickerSNBR.O
SectorConsumer Cyclicals
BusinessCyclical Consumer Products
Industry groupCyclical Consumer Products
IndustryHome Furnishings
AI analysis

Business. Sleep Number Corp designs, markets, and sells adjustable air mattress systems and related products, primarily through direct-to-consumer channels and retail partners.

Classification. Sleep Number is classified in the Home Furnishings industry under the Cyclical Consumer Products business sector, with a high confidence level of 0.92 based on verified market data.

Sleep Number's capital structure is highly leveraged, with total liabilities of $1.26 billion and total equity of -$578.5 million, resulting in a debt-to-equity ratio of -1.02. The company's liquidity position is weak, with cash and equivalents of only $1.69 million and a current ratio of 0.16, indicating significant short-term liquidity risk. Profitability metrics show a deteriorating trend, with a net loss of $131.96 million and an operating loss of $46.59 million in the latest period. Return on equity is 22.81%, but this is misleading due to the negative equity base. Return on assets is -19.4%, well below the typical performance of the Home Furnishings industry. The company's revenue is concentrated in the U.S. market, with no material international exposure disclosed. Sleep Number's product portfolio is centered on adjustable beds and related accessories, with no material diversification into other home furnishings categories. Growth prospects are mixed. While the company maintains a market cap of $36.87 million, it has not demonstrated consistent revenue growth in recent periods. The operating cash flow is negative at -$3.28 million, and free cash flow is -$90.76 million, indicating a lack of cash generation to support expansion. The risk profile is elevated, with a medium liquidity risk and a negative net cash position after subtracting total debt. The company has not issued any dilutive shares in the latest period, and the dilution risk is currently low. However, the negative equity position and high leverage could necessitate future capital raises, which would increase dilution risk. Recent filings and transcripts show that Sleep Number is focusing on cost optimization and inventory management to improve its financial position. Analysts have assigned a mean price target of $4.50, with all four recommendations being "Hold".
Key takeaways
  • Sleep Number is operating with a negative equity position and high leverage, indicating significant financial distress.
  • The company's liquidity is critically low, with a current ratio of 0.16 and minimal cash reserves.
  • Despite a high return on equity, the negative equity base makes this metric misleading.
  • Analysts have not issued any "Buy" or "Strong Buy" ratings, reflecting cautious sentiment.
  • The company's growth strategy is constrained by poor cash flow generation and a weak balance sheet.
  • --
  • ## RATIONALES
  • ```json
Financial snapshot
PeriodHA-latest
CurrencyUSD
Revenue$1.41B
Gross profit$842.5M
Operating income-$46.6M
Net income-$132.0M
R&D
SG&A
D&A
SBC
Operating cash flow-$3.3M
CapEx-$14.4M
Free cash flow-$90.8M
Total assets$680.1M
Total liabilities$1.26B
Total equity-$578.5M
Cash & equivalents$1.7M
Long-term debt$588.2M
Valuation
Market price$1.60
Market cap$36.9M
Enterprise value$623.4M
P/E
Reported non-GAAP P/E
EV/Revenue0.4
EV/Op income
EV/OCF
P/B
P/Tangible book
Tangible book-$578.5M
Net cash-$586.5M
Current ratio0.2
Debt/Equity-1.0
ROA-19.4%
ROE22.8%
Cash conversion2.0%
CapEx/Revenue-1.0%
SBC/Revenue
Asset intensity
Dilution ratio0.0%
Risk assessment
Dilution riskLow
Liquidity riskMedium
  • Net cash is negative after subtracting total debt.
Industry benchmarks
Activity: Home Furnishings · cohort 140 companies
MetricSNBRActivity
Op margin-3.3%4.3% medp25 0.1% · p75 10.9%bottom quartile
Net margin-9.3%2.8% medp25 -1.7% · p75 8.2%bottom quartile
Gross margin59.7%30.6% medp25 20.3% · p75 43.6%top quartile
R&D / revenue0.4% medp25 0.4% · p75 0.4%
CapEx / revenue-1.0%-3.1% medp25 -5.6% · p75 -1.6%top quartile
Debt / equity-102.0%30.2% medp25 10.3% · p75 51.3%bottom quartile
Observations
IR observations
Mean price target4.50 USD
Median price target4.50 USD
High price target5.00 USD
Low price target4.00 USD
Mean recommendation3.00 (1=strong buy, 5=strong sell)
Strong-buy count0.00
Buy count0.00
Hold count4.00
Sell count0.00
Strong-sell count0.00
Mean EPS estimate-0.52 USD
Last actual EPS-5.35 USD
Source data
Underlying data the analysis-pipeline pulls and audits. Fetch timestamps + content hashes show when each source was last refreshed.
Company fundamentalsperiod financials
no public URL
2026-05-16 16:08 UTC#03394176
Market quoteclose USD 3.03 · shares 0.02B diluted
no public URL
2026-05-16 16:10 UTC#3c2794a2
Source: analysis-pipeline (hybrid)Generated: 2026-05-29 12:04 UTCJob: 6260db5f